CT GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) at Dr. Essa Lab

Understanding the CT-Guided Biopsy Procedure

A CT-guided biopsy is a highly specialized, minimally invasive interventional radiology procedure that utilizes the advanced imaging capabilities of Computed Tomography (CT) to obtain precise tissue samples from deep-seated lesions, nodules, or masses within the body. By combining real-time, cross-sectional X-ray imaging with clinical expertise, interventional radiologists can navigate a biopsy needle with millimeter-level accuracy to the exact site of concern. This procedure is fundamental in modern diagnostic oncology, pulmonology, and gastroenterology, offering a safer, less invasive alternative to open surgical biopsies while providing definitive histopathological diagnoses.

At Dr. Essa Laboratory & Diagnostic Centre, a premier diagnostic institution in Karachi, Pakistan, this procedure is performed using state-of-the-art multi-slice CT scanners. The term "WITHOUT NEEDLE CHARGES" indicates that the base cost of the procedure covers the CT imaging, the expertise of the consultant interventional radiologist, local anesthesia, and the immediate post-procedure monitoring, while the specialized biopsy needle itself is billed separately. Because different anatomical targets—such as the lung, liver, bone, or retroperitoneum—require highly specific needle types, gauges, and lengths (such as coaxial core needles, fine-needle aspiration needles, or bone biopsy systems), this transparent pricing model ensures patients only pay for the exact medical consumables required for their specific clinical scenario.

Clinical Procedure: What to Expect

Patient Preparation Guidelines

Proper patient preparation is vital to ensure safety, minimize the risk of complications, and guarantee the diagnostic quality of the harvested tissue. Patients scheduled for a CT-guided biopsy at Dr. Essa Lab must adhere to the following clinical guidelines:

• Coagulation Profile: Patients must undergo blood tests, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and International Normalized Ratio (INR), along with a Complete Blood Count (CBC) to assess platelet levels. These tests must be completed within a few days of the procedure to rule out bleeding disorders.
• Medication Adjustments: Blood-thinning medications, antiplatelet agents, and anticoagulants (such as aspirin, clopidogrel, warfarin, or low-molecular-weight heparin) must be temporarily discontinued under the strict guidance of the prescribing physician, typically 3 to 7 days prior to the biopsy.
• Fasting Requirements: Patients are generally required to fast (nil per os) for 4 to 6 hours before the procedure, especially if mild conscious sedation is planned or if the biopsy target is within the abdomen or pelvis.
• Medical History Disclosure: It is essential to inform the clinical team of any allergies, particularly to local anesthetics (like lidocaine), contrast media, or latex, as well as any possibility of pregnancy.
• Prior Imaging: Patients must bring all previous diagnostic reports, including chest X-rays, prior CT scans, MRI reports, or PET scans, to assist the radiologist in planning the optimal needle trajectory.

During the Procedure

The procedure is performed in a dedicated CT suite under sterile conditions. The patient is positioned on the CT scanner table in a prone, supine, or lateral decubitus position, depending on the anatomical location of the target lesion. An initial planning CT scan is performed to localize the lesion and determine the safest, most direct pathway that avoids major blood vessels, nerves, and vital organs.

Once the optimal entry point is identified, the patient's skin is marked, thoroughly cleansed with an antiseptic solution (such as chlorhexidine), and covered with sterile drapes. The radiologist then administers a local anesthetic (typically 1% or 2% lidocaine) to numb the skin, subcutaneous tissues, and deeper pathways along the planned needle track. A tiny skin nick (approximately 1 to 2 millimeters) is made to facilitate the insertion of the biopsy needle.

Under intermittent CT guidance, the radiologist carefully advances the biopsy needle into the target tissue. Real-time scans verify the precise position of the needle tip within the lesion. Once confirmed, tissue cores or fluid aspirates are acquired. Multiple samples may be taken to ensure adequate diagnostic yield. After the samples are secured, the needle is removed, pressure is applied to the site to prevent bleeding, and a sterile dressing is applied. A final post-procedure CT scan is often performed to check for immediate complications, such as a pneumothorax (collapsed lung) in lung biopsies or a hematoma in abdominal biopsies. The patient is then monitored in a recovery area for 2 to 4 hours before discharge.

When is a CT GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) Performed?

Evaluation of Suspected Pulmonary Nodules or Masses

Physicians request a CT-guided lung biopsy when routine chest radiographs or diagnostic CT scans reveal indeterminate pulmonary nodules, focal consolidations, or hilar masses. This procedure is essential for differentiating between malignant primary lung cancers (such as adenocarcinoma or squamous cell carcinoma), metastatic lesions from other primary sites, and benign infectious processes like tuberculosis or fungal infections. The high precision of CT guidance allows safe access to peripheral lung lesions while minimizing the risk of a pneumothorax.

Investigation of Hepatic or Abdominal Lesions

A CT-guided biopsy of the liver or abdominal cavity is indicated when non-invasive imaging cannot definitively characterize focal liver masses, suspected metastatic deposits, or peritoneal nodules. It is highly valuable in patients with a history of malignancy who present with new abdominal lesions, helping clinicians distinguish between tumor recurrence, primary hepatocellular carcinoma, benign focal nodular hyperplasia, or localized abdominal infections such as pyogenic or amebic abscesses.

Diagnosis of Deep-Seated Retroperitoneal Masses

The retroperitoneal space contains critical structures, including major blood vessels like the aorta and inferior vena cava, making blind or ultrasound-guided biopsies highly risky. CT-guided biopsy provides the necessary spatial resolution to safely navigate around these vital structures to sample retroperitoneal lymph nodes, suspected sarcomas, or deep pelvic masses, facilitating accurate staging and treatment planning for lymphomas and other retroperitoneal malignancies.

Characterization of Musculoskeletal and Bone Tumors

Musculoskeletal biopsies are performed to evaluate osteolytic, osteoblastic, or soft-tissue masses associated with the skeletal system. When a patient presents with localized bone pain and imaging shows suspicious bone destruction, a CT-guided bone biopsy is utilized to obtain cortical or marrow samples. This helps diagnose primary bone malignancies (such as osteosarcoma or Ewing sarcoma), metastatic bone disease, or infectious osteomyelitis, guiding orthopedic oncologists in planning limb-salvage surgeries or systemic therapies.

Assessment of Renal and Adrenal Masses

Atypical renal parenchymal masses or adrenal nodules often require histopathological confirmation when imaging features are inconclusive. A CT-guided biopsy is requested to differentiate between renal cell carcinoma, benign oncocytomas, adrenal adenomas, or metastatic disease. This is particularly crucial for patients who are poor candidates for immediate surgery, allowing clinicians to establish a definitive diagnosis and implement targeted medical therapies or active surveillance protocols.

What Does a CT GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) Detect?

A CT-guided biopsy is a definitive diagnostic tool capable of detecting a wide array of malignant, benign, infectious, and inflammatory conditions across various organ systems. Some of the primary findings include:

• Adenocarcinoma of the Lung: A common form of non-small cell lung cancer characterized by glandular differentiation.
• Squamous Cell Carcinoma: A malignant epithelial tumor frequently located in the central airways or head and neck regions.
• Small Cell Lung Cancer: An aggressive neuroendocrine tumor requiring rapid systemic chemotherapy.
• Hepatocellular Carcinoma (HCC): Primary liver cancer, often arising in the setting of chronic cirrhosis or hepatitis.
• Metastatic Carcinoma: Secondary tumor deposits originating from primary sites such as the breast, colon, prostate, or kidney.
• Renal Cell Carcinoma (RCC): The most common primary malignant tumor of the kidney cortex.
• Adrenal Adenoma: A benign neoplasm of the adrenal cortex, which may or may not be hormonally active.
• Lymphoma (Hodgkin and Non-Hodgkin): Malignancies of the lymphatic system presenting as nodal or extranodal masses.
• Liposarcoma: A malignant tumor of fat cells, commonly found in the retroperitoneum.
• Osteosarcoma: A primary malignant bone tumor characterized by the production of osteoid.
• Tuberculosis (TB): Characterized by caseating granulomatous inflammation and the presence of acid-fast bacilli.
• Sarcoidosis: A systemic inflammatory disease marked by non-caseating granulomas in multiple organs.
• Aspergillosis: A fungal infection that can present as a pulmonary cavity mass (aspergilloma).
• Pyogenic Abscess: A localized collection of pus caused by bacterial infection within parenchymal organs.
• Focal Nodular Hyperplasia (FNH): A benign, regenerative liver lesion characterized by a central stellate scar.
• Chronic Osteomyelitis: Long-standing bacterial infection of the bone marrow and surrounding cortex.
• Pheochromocytoma: A rare, catecholamine-secreting tumor of the adrenal medulla.
• Organizing Pneumonia: A benign, inflammatory lung condition that can radiologically mimic malignancy.
• Amyloidosis: Extracellular deposition of insoluble amyloid fibrils in organs like the kidneys or liver.
• Granulomatosis with Polyangiitis: A systemic necrotizing vasculitis affecting small-to-medium-sized blood vessels.

Turnaround Time and Report Access at Dr. Essa Lab

Once the tissue sample is successfully harvested during the CT-guided biopsy, it is immediately placed in a preservative solution (typically 10% neutral buffered formalin) and transferred to the state-of-the-art histopathology department at Dr. Essa Laboratory & Diagnostic Centre. Here, expert pathologists process the tissue, perform microtome sectioning, and apply hematoxylin and eosin (H&E) stains for microscopic evaluation.

The standard turnaround time for a routine histopathology report is typically 3 to 5 working days. However, if the lesion is complex or highly undifferentiated, additional specialized testing such as Immunohistochemistry (IHC) or special histochemical stains may be required to establish an exact molecular diagnosis. These advanced tests may add 2 to 3 days to the final reporting timeline. Dr. Essa Lab provides convenient digital report access, allowing patients and their referring physicians to view and download highly detailed diagnostic reports online through the official web portal or mobile application, as well as collect physical copies from any of their extensive diagnostic networks across Karachi.

CT GUIDED BIOPSY (WITHOUT NEEDLE CHARGES) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Lung Parenchyma	Normal alveoli, bronchioles, and vascular structures without cellular atypia.	Adenocarcinoma, squamous cell carcinoma, caseating granulomatous inflammation (Tuberculosis).
Hepatic Tissue	Normal lobular architecture, hepatocytes, and portal triads without inflammation or fibrosis.	Hepatocellular carcinoma, metastatic adenocarcinoma, focal nodular hyperplasia, hepatic abscess.
Bone Matrix & Marrow	Normal trabecular bone, osteocytes, and active hematopoietic marrow elements.	Osteosarcoma, metastatic bone disease, osteolytic lesions, chronic bacterial osteomyelitis.
Lymph Nodes	Normal nodal architecture with preserved germinal centers and sinus histiocytosis.	Hodgkin or Non-Hodgkin lymphoma, metastatic carcinoma deposits, granulomatous lymphadenitis.
Renal Parenchyma	Normal glomeruli, proximal and distal convoluted tubules, and interstitial spaces.	Renal cell carcinoma (clear cell or papillary), interstitial nephritis, amyloid deposits.
Adrenal Gland	Normal cortical layers (glomerulosa, fasciculata, reticularis) and medullary chromaffin cells.	Adrenal cortical carcinoma, benign adrenal adenoma, pheochromocytoma, metastatic disease.
Soft Tissue / Retroperitoneum	Normal fibroadipose tissue, skeletal muscle fibers, and benign stromal elements.	Liposarcoma, leiomyosarcoma, fibromatosis, desmoid tumors, acute inflammatory phlegmon.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for CT GUIDED BIOPSY (WITHOUT NEEDLE CHARGES)?

• Legacy of Trust: Established in 1987, Dr. Essa Lab is one of Pakistan's most respected and trusted diagnostic networks, known for clinical excellence.
• Expert Interventional Radiologists: The procedure is performed by highly qualified, experienced consultant interventional radiologists specializing in image-guided procedures.
• Advanced Multi-Slice CT Technology: Dr. Essa Lab utilizes state-of-the-art, high-resolution CT scanners that ensure maximum needle precision and patient safety.
• Accurate Histopathology Department: Tissue samples are analyzed by senior consultant pathologists utilizing advanced immunohistochemistry for precise tumor typing.
• Rigorous Quality Control: The laboratory adheres to strict international quality control standards, ensuring highly reliable and reproducible diagnostic reports.
• Transparent Pricing: The "without needle charges" model ensures patients only pay for the specific biopsy needle required for their unique anatomical site.
• Convenient Digital Access: Patients can easily access their diagnostic reports online via the official Dr. Essa Lab website or dedicated mobile application.
• Patient-Centric Care: From pre-procedure preparation to post-biopsy monitoring, Dr. Essa Lab provides a compassionate, sterile, and highly supportive environment.